TENAX THERAPEUTICS, INC. 4
4 · TENAX THERAPEUTICS, INC. · Filed Apr 5, 2017
Insider Transaction Report
Form 4
Jebsen Michael B
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2017-04-03+200,000→ 200,000 totalExercise: $0.53Exp: 2027-04-03→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in four equal annual installments beginning on April 3, 2018, however, the vesting of the option will accelerate and become fully vested upon the achievement of specified performance goals.